Elanco Animal Health Incorporated (ELAN) Stock Forecast
ELAN analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 4.50 / 5 from 16 analysts
- Price target
- $30.85 average of analyst targets
- Upside to target
- +31.0% from the latest close
- Next earnings
- November 6, 2026 EPS estimate $0.20
- 52-week range
- $19.80 – $26.84
ELAN analyst ratings
16 analystsNumber of analysts at each rating.
ELAN price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ELAN earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.21 | $0.19 | $0.24 | $0.19 | +8.8% | 12 |
| Current fiscal year (2026) | $1.14 | $1.10 | $1.22 | $0.94 | +20.9% | 14 |
| Next fiscal year (2027) | $1.29 | $1.22 | $1.44 | $1.14 | +13.3% | 14 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ELAN revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.21B | $1.20B | $1.23B | +6.2% | 10 |
| Current fiscal year (2026) | $5.13B | $5.10B | $5.20B | +8.8% | 12 |
| Next fiscal year (2027) | $5.41B | $5.31B | $5.60B | +5.5% | 12 |
ELAN EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ELAN revenue: reported and forecast
ELAN EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.19 | $0.20 | $0.21 | $0.21 | $0.21 | +6.2% | 9 up · 1 down |
| Current fiscal year (2026) | $1.07 | $1.13 | $1.14 | $1.13 | $1.14 | +6.7% | 2 up · 0 down |
| Next fiscal year (2027) | $1.20 | $1.26 | $1.29 | $1.28 | $1.29 | +7.7% | 3 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ELAN earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ELAN beat in 10 of 12.
What analysts expect from ELAN
16 analysts cover Elanco Animal Health; their consensus rating is strong buy (4.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $30.85, 31.0% above the latest close of $23.55. Analysts expect earnings of $1.14 per share for 2026, +20.9% from a year earlier. For 2027 the average estimate is $1.29 per share on revenue of $5.4 billion. Elanco Animal Health beat the EPS estimate in 10 of the last 12 quarters.
Related: ELAN income statement, ELAN key metrics, ELAN chart. See the ELAN stock overview for the latest quote and news.
ELAN forecast FAQ
What is Elanco Animal Health's price target?
The average analyst price target for Elanco Animal Health is $30.85, 31.0% above the latest close of $23.55.
Is Elanco Animal Health a buy, hold or sell?
Of 16 analysts covering Elanco Animal Health, 10 rate it a strong buy, 4 a buy, 2 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Elanco Animal Health's EPS forecast?
Analysts forecast $1.14 per share for 2026 (range $1.10 to $1.22); for 2027 the estimate is $1.29.
What is Elanco Animal Health's revenue forecast?
The average revenue estimate for 2026 is $5.1 billion, growth of 8.8%; for 2027 it is $5.4 billion.
When does Elanco Animal Health report earnings?
Elanco Animal Health is expected to report results for the quarter ending September 30, 2026 on November 6, 2026 before the market opens; the EPS estimate is $0.20.
Does Elanco Animal Health usually beat earnings estimates?
Elanco Animal Health reported EPS at or above the analyst estimate in 10 of the last 12 quarters.